Show simple item record

FieldValueLanguage
dc.contributor.authorMemari, Niloofar
dc.contributor.authorHayen, Andrew
dc.contributor.authorBell, Katy J.L.
dc.contributor.authorRychetnik, Lucie
dc.contributor.authorMorton, Rachael L
dc.contributor.authorMcCaffery, Kirsten
dc.contributor.authorThompson, John F
dc.contributor.authorIrwig, Les
dc.contributor.authorTurner, Robin M
dc.date.accessioned2021-04-22T05:35:07Z
dc.date.available2021-04-22T05:35:07Z
dc.date.issued2015en
dc.identifier.urihttps://hdl.handle.net/2123/24969
dc.description.abstractPost-treatment follow-up for patients with American Joint Committee on Cancer (AJCC) stage I/II melanoma is believed to be important for early detection of disease recurrence and new primary melanomas, but comes with costs to both patients and healthcare providers. We aimed to determine how frequently a cohort of patients attended follow-up after surgical treatment at one Specialist Center.en
dc.language.isoenen
dc.publisher2015en
dc.relation.ispartofAnnals of Surgical Oncologyen
dc.rightsCopyright All Rights Reserveden
dc.subjectmelanomaen
dc.subjectCutaneous Melanomaen
dc.subjectSpecialist Centeren
dc.subjectPrimary Melanomaen
dc.subjectshared careen
dc.titleHow often do patients with localized melanoma attend follow-up at a specialist center?en
dc.typeArticleen
dc.subject.asrc1112 Oncology and Carcinogenesisen
dc.subject.asrc1117 Public Health and Health Servicesen
dc.identifier.doi10.1245/s10434-015-4589-x
dc.relation.nhmrc633003
dc.relation.nhmrc1013390
dc.relation.nhmrc1054216
dc.relation.nhmrc1029241
usyd.facultySeS faculties schools::Faculty of Medicine and Health::Sydney School of Public Healthen
usyd.citation.volume22en
usyd.citation.spage1164en
usyd.citation.epage1171en
workflow.metadata.onlyYesen


Show simple item record

Associated file/s

Associated collections

Show simple item record

There are no previous versions of the item available.